{"database": "lobbying", "table": "lobbying_activities", "rows": [[1345229, "511eadad-5ed3-4357-92b9-34d7dce0ec06", "Q4", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2012, "fourth_quarter", "PHA", "**see addendum page Prescription drug importation\n     S. 319  Pharmaceutical Market Access and Drug Safety Act of 2011\n     H.R. 147 - Prescription Drug Affordability Act\n     S. 296 - Drug Shortage Act\n\nPL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation \n \n***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2013-01-18T15:27:05.300000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1345229"], "units": {}, "query_ms": 4.680926911532879, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}